Curosurf surfactant application on preterm babies with respiratory complications-health-economic benefits.

Autor:	Mihaylova A; Department of Health Care Management, Faculty of Public Health, Medical University of Plovdiv, Plovdiv, Bulgaria, 15A Vasil Aprilov str., 4002 Plovdiv, Bulgaria., Kristina K; Department of Medical Informatics, Biostatistics and e-Learning, Faculty of Public Health, Medical University of Plovdiv, Plovdiv, Bulgaria, 15A Vasil Aprilov str., 4002 Plovdiv, Bulgaria., Kasnakova P; Department of Health Care Management, Faculty of Public Health, Medical University of Plovdiv, Plovdiv, Bulgaria, 15A Vasil Aprilov str., 4002 Plovdiv, Bulgaria., Gueorguiev S; Department of Pharmaceutical Sciences, Faculty of Pharmacy, Medical University of Plovdiv, Plovdiv, Bulgaria, 15A Vasil Aprilov str., 4002 Plovdiv, Bulgaria., Gueorguieva P; Department of health policy and management, Faculty of Public Health, Medical University of Sofia, 15 Akademik Ivan Evstratiev Geshov Blvd., 1431 Sofia, Bulgaria., Bakova D; Department of Health Care Management, Faculty of Public Health, Medical University of Plovdiv, Plovdiv, Bulgaria, 15A Vasil Aprilov str., 4002 Plovdiv, Bulgaria., Parahuleva N; Department of Obstetrics and Gynaecology, Medical University of Plovdiv, Plovdiv, Bulgaria, 15A Vasil Aprilov str., 4002 Plovdiv, Bulgaria.
Jazyk:	angličtina
Zdroj:	African health sciences [Afr Health Sci] 2024 Mar; Vol. 24 (1), pp. 220-227.
DOI:	10.4314/ahs.v24i1.27
Abstrakt:	Background: The implementation of surfactant for respiratory syndrome approbates the therapy as a revolutionary method in intensive neonatal therapy and respiratory resuscitation. It is important to investigate the costs of this treatment. Objective: The aim of the study is to analyze the data by the application of the surfactant Curosurf to preterm babies with respiratory complications and describe the treatment costs, healthcare resource utilization and evaluate economic benefits of surfactant use in the treatment of neonates with respiratory distress syndrome (RDS) and hyaline-membrane disease (HDM). Methods: A retrospective survey was performed covering 167 babies based on respiratory complications due to preterm birth and the necessity to apply a surfactant therapy. A documentary method was implemented and for each patient, an individual research protocol was filled out - a questionnaire created specifically for the purposes of the study. Results and Discussion: An analysis of the data from the application of CUROSURF was made and the obtained therapeutic results were compared to expenditures for the therapy, short-term therapeutic effect, benefits and consequences of the therapy of preterm newborns with respiratory complications. The application of CUROSURF to babies with RDS resulted in the realization of net savings due to the elimination of the necessity of conducting several diagnostic and therapeutic procedures as well as their duration reduction of hospital stay, thus defining its health-economic benefits. Conclusions: The models of evaluation of cost effectiveness reveal that the medicinal product is expensive but effective from the aspect of short-term therapeutic results. Competing Interests: The authors report no conflicts of interest in this work. (© 2024 Mihaylova A et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu